OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI ...
Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...
OpenAI CEO Sam Altman will brief U.S. officials on super-agents—AI systems set to revolutionize software development, finance ...
Retro Biosciences Inc., a startup using artificial intelligence to discover new drugs, is reportedly raising $1 billion in ...
Latin Times on MSN20h
Trump Staff 'Furious' at Elon Musk for Panning President's $500 Billion AI Deal: 'Elon Gives Zero F–s'Elon Musk's criticism of President Trump's $500 billion Stargate AI initiative has sparked outrage among White House aides.
Sam Altman, the CEO of OpenAI, now says he is more confident of a fast AI takeoff. A fast AI takeoff is more possible than he ...
"And of course it's smarter than us. Of course, it can do things we can't, but also who really cares? I think it's only weird ...
The $500 billion Stargate Initiative — led by Trump, OpenAI, SoftBank, and Oracle — is set to revolutionize U.S. AI ...
Stargate is little more than an extension of Sam Altman's powerful AI company, anonymous sources told the Financial Times.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback